Home » Chinese Neptunus Unit to List in Hong Kong
Chinese Neptunus Unit to List in Hong Kong
China's Securities Regulatory Commission has approved a Hong Kong listing for a unit of Chinese drugmaker Neptunus. The subsidiary, Shenzhen Neptunus Yingtelong Bioengineering, is 90% owned by its listed parent, and will await approval from the Hong Kong Stock Market before proceeding with the IPO. Shenzhen Neptunus Yingtelong, which makes a number of pharmaceuticals and health products, reported assets of CNY134.27mn (US$16.22mn) at the end of 2003.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
18Jul
-
21Oct